Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing

NCT04981119 is registered in ClinicalTrials.gov with A2 Biotherapeutics Inc. as lead sponsor.

NCT NCT04981119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04981119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing
Lead sponsor
A2 Biotherapeutics Inc.
Phase
Observational
Overall status
Recruiting
Start date
October 29, 2021
Completion date
April 30, 2029
Enrollment
500 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, colorectal cancer, crc, head and neck squamous cell carcinoma hnscc, mesothelioma, mesothelioma, malignant, mesothelioma; lung, non small cell lung cancer, nsclc, ovarian cancer, ovarian carcinoma, ovarian neoplasms, pancreas cancer, pancreatic cancer, renal cell carcinoma (kidney cancer), solid tumor, adult, triple negative breast cancer (tnbc)